Cover Image

ICAM-1 Targeted Drug Combination Nanoparticles Enhanced Gemcitabine-Paclitaxel Exposure and Breast Cancer Suppression in Mouse Models

Despite the availability of molecularly targeted treatments such as antibodies and small molecules for human epidermal growth factor receptor 2 (HER2), hormone receptor (HR), and programmed death-ligand 1 (PD-L1), limited treatment options are available for advanced metastatic breast cancer (MBC), w...

Full description

Saved in:

Bibliographic Details
Main Authors:	Linxi Zhu (Author), Qingxin Mu (Author), Jesse Yu (Author), James I. Griffin (Author), Xiaolin Xu (Author), Rodney J. Y. Ho (Author)
Format:	Book
Published:	MDPI AG, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design and Characterization of a Novel Venetoclax-Zanubrutinib Nano-Combination for Enhancing Leukemic Cell Uptake and Long-Acting Plasma Exposure
by: James Griffin, et al.
Published: (2023)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019)

Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020)

Surface-Modification of Carbonate Apatite Nanoparticles Enhances Delivery and Cytotoxicity of Gemcitabine and Anastrozole in Breast Cancer Cells
by: Fitya Syarifa Mozar, et al.
Published: (2017)

A combination of paclitaxel and gemcitabine in an intensive dose-dense neoadjuvant chemotherapy schedule for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014)

Enhancing Paclitaxel Efficacy with Piperine-Paclitaxel Albumin Nanoparticles in Multidrug-Resistant Triple-Negative Breast Cancer by Inhibiting P-Glycoprotein
by: Wenwen Xu, et al.
Published: (2023)

Intensified dose-dense neoadjuvant chemotherapy using paclitaxel-gemcitabine and docetaxel-doxorubicin combinations for locally advanced breast cancer
by: I. V. Frai, et al.
Published: (2014)

Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil
by: Adriana Samide, et al.
Published: (2021)

Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score-matched analysis of real-world data
by: Chengcheng Gong, et al.
Published: (2022)

l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells
by: Shiwei Niu, et al.
Published: (2018)

Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
by: Qiwei Wu, et al.
Published: (2022)

Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy
by: Zheng Zhai, et al.
Published: (2020)

Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
by: Lu Qin, et al.
Published: (2021)

Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib
by: Yin N, et al.
Published: (2020)

MMI-0100 ameliorates lung inflammation in a mouse model of acute respiratory distress syndrome by reducing endothelial expression of ICAM-1
by: He B, et al.
Published: (2018)

Intra-vaginal gemcitabine-hybrid nanoparticles for effective cervical cancer treatment
by: Mona Elhabak, et al.
Published: (2022)

Risk factors for interstitial lung disease induced by gemcitabine plus albumin-bound paclitaxel therapy in pancreatic ductal adenocarcinoma patients
by: Rikako Ueda, et al.
Published: (2022)

Editorial: Nanoparticles in Cancer Therapy-Novel Concepts, Mechanisms, and Applications
by: Qingxin Mu, et al.
Published: (2019)

Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance
by: Su Y, et al.
Published: (2017)

Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models
by: Hang Chen, et al.
Published: (2021)

Vitrification of mouse MII oocytes: Developmental competency using paclitaxel
by: Farzaneh Fesahat, et al.
Published: (2016)

Preparation and characterization of gemcitabine particles for oral delivery
by: Ji-Ho Lim, et al.
Published: (2012)

Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
by: Eduardo García-Garrido, et al.
Published: (2021)

Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients
by: Zhenhua Du, et al.
Published: (2015)

Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles
by: Lingyan Lv, et al.
Published: (2020)

M1 macrophage-membrane-cloaked paclitaxel/β-elemene nanoparticles targeting cervical cancer for enhanced therapy
by: Yi Wang, et al.
Published: (2024)

Nucleobase-crosslinked poly(2-oxazoline) nanoparticles as paclitaxel carriers with enhanced stability and ultra-high drug loading capacity for breast cancer therapy
by: Si Dong, et al.
Published: (2022)

Recent advancements in the targeted delivery of Gemcitabine: Harnessing nanomedicine for enhanced cancer therapy
by: Mehrab Pourmadadi, et al.
Published: (2023)

Tissue distribution of crizotinib and gemcitabine combination in a patient-derived orthotopic mouse model of pancreatic cancer
by: Richard J. Honeywell, et al.
Published: (2016)

Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery
by: Sankha Bhattacharya, et al.
Published: (2022)

Antibodies Enhance the Suppressive Activity of Extracellular Vesicles in Mouse Delayed-Type Hypersensitivity
by: Katarzyna Nazimek, et al.
Published: (2021)

Design and Characterization of Paclitaxel-Loaded Polymeric Nanoparticles Decorated With Trastuzumab for the Effective Treatment of Breast Cancer
by: Mirina Sakhi, et al.
Published: (2022)

Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles
by: Fatemeh Madani, et al.
Published: (2018)

Effect of polymeric stabilizers on the size and stability of PLGA paclitaxel nanoparticles
by: Mirina Sakhi, et al.
Published: (2023)

Gemcitabine and taxanes in metastatic breast cancer: a systematic review
by: Vinay Gudena, et al.
Published: (2008)

Precise engineering of Gemcitabine prodrug cocktails into single polymeric nanoparticles delivery for metastatic thyroid cancer cells
by: Chenggong Liu, et al.
Published: (2020)

Complete response of refractory mycosis fungoides to treatment of pancreatic cancer with combination gemcitabine and nab-paclitaxel: A possible new regimen for the treatment of advanced cutaneous T-cell lymphoma
by: Michelle Pratt, MD, et al.
Published: (2020)

IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM-1 release inhibits human rhinovirus infection
by: Spiteri Monica A, et al.
Published: (2008)

Enhanced tumor targeting effects of a novel paclitaxel-loaded polymer: PEG-PCCL-modified magnetic iron oxide nanoparticles
by: Xinyi Li, et al.
Published: (2017)

Self-assembled nanoformulations of paclitaxel for enhanced cancer theranostics
by: Qing Pei, et al.
Published: (2023)